TPU-006
Post-Surgical Pain Management
Phase 2Active
Key Facts
About Teikoku Pharma
Teikoku Pharma USA, founded in 1999, is a commercial-stage biopharmaceutical company with deep expertise in transdermal drug delivery systems. The company leverages its proprietary Hydrohesive® and Matrix patch technologies to develop non-opioid pain management solutions and treatments for CNS disorders, with a pipeline featuring late-stage assets like TPU-006 for post-surgical pain. With a marketed product generating revenue and a strategic focus on global partnerships and licensing, Teikoku is positioned to address significant unmet needs in pain management and neurology.
View full company profileTherapeutic Areas
Other Post-Surgical Pain Management Drugs
| Drug | Company | Phase |
|---|---|---|
| ON-Q/ambIT Pumps (NOPAIN Act) | Avanos Medical | Commercial Expansion |
| Ropivacaine Readyfusor | BioQ Pharma | Approved |